Tag: TEVA

On February 26, 2024, Teva's stock price surged after receiving FDA approval for its groundbreaking arthritis medication, SIMLANDI® (adalimumab-ryvk) injection. ...

On February 12, 2024, David Amsellem, an analyst at Teva Pharmaceutical Industries, expressed his optimistic stance on the Austedo franchise, ...

The analysis of Teva Pharmaceutical Industries by a group of eight analysts in the past three months has yielded a ...